Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A synthetic purine analog and experimental small molecule compound belonging to the class of organic compounds known as 6‑aminopurines. It features a phosphonomethoxy side chain at the 9-position and amino groups at positions 2 and 6 of the purine ring. The compound is structurally related to other nucleotide analogs but is not approved for clinical use or any therapeutic indication. Its mechanism of action has not been fully elucidated; however, it has been identified as a ligand for purine nucleoside phosphorylase in structural biology studies[4]. There are no reported clinical trials or approved uses for this molecule[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 2,6-diamino-(S)-9-[2-(phosphonomethoxy)propyl]purine.